Bruker Corp - Understand $brkr stock

$BRKR Market Cap: $9.845 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$3.120B

TTM

Gross Margin

49.7%

TTM

Net Earnings

$352.1M

TTM

Current Assets

$2.153B

Q2 2024

Current Liabilities

$1.305B

Q2 2024

Current Ratio

165.04%

Q2 2024

Total Assets

$5.903B

Q2 2024

Total Liabilities

$4.096B

Q2 2024

Book Value

$1.807B

Q2 2024

Cash

$169.7M

Q2 2024

P/E

27.96

Sep 17, 2024 EST

Free Cash Flow

$166.5M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$2.965B	$2.531B	$2.418B	$1.988B	$2.073B	$1.896B	$1.766B	$1.611B	$1.624B	$1.809B	$1.839B	$1.791B	$1.652B	$1.305B	$1.115B	$1.107B	$1.032B	$851.4M	$372.3M	$357.0M	$260.7M	$220.7M	$175.3M
YoY Change	17.14%	4.67%	21.66%	-4.11%	9.34%	7.34%	9.59%	-0.77%	-10.23%	-1.66%	2.68%	8.46%	26.58%	17.08%	0.67%	7.24%	21.26%	128.69%	4.29%	36.94%	18.12%	25.9%	21.15%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$2.965B	$2.531B	$2.418B	$1.988B	$2.073B	$1.896B	$1.766B	$1.611B	$1.624B	$1.809B	$1.839B	$1.791B	$1.652B	$1.305B	$1.115B	$1.107B	$1.032B	$851.4M	$372.3M	$357.0M	$260.7M	$220.7M	$175.3M
Cost Of Revenue	$1.451B	$1.225B	$1.208B	$1.048B	$1.077B	$995.6M	$949.9M	$866.0M	$915.2M	$1.046B	$1.034B	$962.0M	$899.2M	$700.9M	$597.0M	$602.1M	$556.8M	$450.9M	$206.3M	$206.1M	$154.3M	$119.0M	$94.70M
Gross Profit	$1.513B	$1.306B	$1.210B	$939.8M	$995.3M	$900.0M	$816.0M	$745.3M	$708.6M	$763.3M	$805.2M	$829.4M	$752.5M	$604.0M	$517.5M	$505.0M	$475.6M	$400.5M	$166.0M	$150.9M	$106.4M	$101.7M	$80.60M
Gross Profit Margin	51.05%	51.59%	50.03%	47.29%	48.02%	47.48%	46.21%	46.25%	43.64%	42.2%	43.78%	46.3%	45.56%	46.29%	46.43%	45.61%	46.07%	47.04%	44.59%	42.27%	40.81%	46.08%	45.98%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Selling, General & Admin	$729.4M	$607.4M	$562.3M	$468.6M	$500.2M	$444.7M	$415.2M	$389.8M	$392.6M	$454.2M	$437.9M	$440.4M	$406.6M	$301.1M	$254.0M	$252.7M	$219.7M	$186.0M	$96.10M	$95.90M	$69.00M	$63.40M	$49.80M
YoY Change	20.09%	8.02%	20.0%	-6.32%	12.48%	7.11%	6.52%	-0.71%	-13.56%	3.72%	-0.57%	8.31%	35.04%	18.54%	0.51%	15.02%	18.12%	93.55%	0.21%	38.99%	8.83%	27.31%	37.57%
% of Gross Profit	48.2%	46.52%	46.49%	49.86%	50.26%	49.41%	50.88%	52.3%	55.41%	59.5%	54.38%	53.1%	54.03%	49.85%	49.08%	50.04%	46.19%	46.44%	57.89%	63.55%	64.85%	62.34%	61.79%
Research & Development	$294.8M	$235.9M	$220.8M	$198.0M	$187.7M	$173.4M	$161.6M	$147.9M	$145.7M	$174.2M	$190.5M	$195.3M	$177.2M	$141.4M	$126.4M	$133.8M	$110.8M	$102.6M	$47.50M	$48.40M	$37.20M	$30.60M	$26.20M
YoY Change	24.97%	6.84%	11.52%	5.49%	8.25%	7.3%	9.26%	1.51%	-16.36%	-8.56%	-2.46%	10.21%	25.32%	11.87%	-5.53%	20.76%	7.99%	116.0%	-1.86%	30.11%	21.57%	16.79%	1.16%
% of Gross Profit	19.48%	18.07%	18.25%	21.07%	18.86%	19.27%	19.8%	19.84%	20.56%	22.82%	23.66%	23.55%	23.55%	23.41%	24.43%	26.5%	23.3%	25.62%	28.61%	32.07%	34.96%	30.09%	32.51%
Depreciation & Amortization	$114.9M	$88.80M	$89.10M	$80.40M	$75.60M	$64.90M	$63.90M	$54.30M	$53.30M	$59.70M	$61.30M	$59.10M	$52.90M	$36.10M	$29.70M	$29.30M	$27.90M	$26.00M	$10.50M	$11.20M	$10.40M	$6.300M	$8.900M
YoY Change	29.39%	-0.34%	10.82%	6.35%	16.49%	1.56%	17.68%	1.88%	-10.72%	-2.61%	3.72%	11.72%	46.54%	21.55%	1.37%	5.02%	7.31%	147.62%	-6.25%	7.69%	65.08%	-29.21%
% of Gross Profit	7.59%	6.8%	7.37%	8.56%	7.6%	7.21%	7.83%	7.29%	7.52%	7.82%	7.61%	7.13%	7.03%	5.98%	5.74%	5.8%	5.87%	6.49%	6.33%	7.42%	9.77%	6.19%	11.04%
Operating Expenses	$1.076B	$873.0M	$783.1M	$691.5M	$694.4M	$637.6M	$596.5M	$537.7M	$548.5M	$628.4M	$657.0M	$673.4M	$596.9M	$448.3M	$380.4M	$388.3M	$330.5M	$288.6M	$143.5M	$144.3M	$106.4M	$94.10M	$76.00M
YoY Change	23.3%	11.48%	13.25%	-0.42%	8.91%	6.89%	10.94%	-1.97%	-12.71%	-4.35%	-2.44%	12.82%	33.15%	17.85%	-2.03%	17.49%	14.52%	101.11%	-0.55%	35.62%	13.07%	23.82%	22.19%
Operating Profit	$436.9M	$432.7M	$426.5M	$248.3M	$300.9M	$262.4M	$219.5M	$207.6M	$160.1M	$134.9M	$148.2M	$156.0M	$155.6M	$155.7M	$137.1M	$116.7M	$145.1M	$111.9M	$22.50M	$6.600M	$0.00	$7.600M	$4.600M
YoY Change	0.97%	1.45%	71.77%	-17.48%	14.67%	19.54%	5.73%	29.67%	18.68%	-8.97%	-5.0%	0.26%	-0.06%	13.57%	17.48%	-19.57%	29.67%	397.33%	240.91%	6327407177142843.0%	-100.0%	65.22%	27.78%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Interest Expense	-$36.80M	$16.10M	-$17.50M	$14.40M	$16.00M	$12.60M	$15.40M	-$8.600M	-$17.30M	-$14.50M	$13.40M	$14.30M	$7.300M	$5.600M	-$8.400M	-$18.00M	$4.200M	-$2.800M	-$900.0K	-$2.400M	$1.200M	$1.700M	$2.200M
YoY Change	-328.57%	-192.0%	-221.53%	-10.0%	26.98%	-18.18%	-279.07%	-50.29%	19.31%	-208.21%	-6.29%	95.89%	30.36%	-166.67%	-53.33%	-528.57%	-250.0%	211.11%	-62.5%	-300.0%	-29.41%	-22.73%
% of Operating Profit	-8.42%	3.72%	-4.1%	5.8%	5.32%	4.8%	7.02%	-4.14%	-10.81%	-10.75%	9.04%	9.17%	4.69%	3.6%	-6.13%	-15.42%	2.89%	-2.5%	-4.0%	-36.36%	1150437668571428.0%	22.37%	47.83%
Other Income/Expense, Net	-$36.80M	-$18.80M	-$2.200M	-$22.50M	-$20.50M	-$17.70M	-$21.70M	-$4.800M	-$200.0K	$2.100M	-$23.60M	-$17.70M	-$10.10M	-$5.600M	$800.0K	$3.000M	$1.600M	$7.500M	$100.0K	-$100.0K	$0.00	$0.00	$100.0K
YoY Change	95.74%	754.55%	-90.22%	9.76%	15.82%	-18.43%	352.08%	2300.0%	-109.52%	-108.9%	33.33%	75.25%	80.36%	-800.0%	-73.33%	87.5%	-78.67%	7400.0%	-200.0%			-100.0%	-66.67%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Pretax Income	$544.2M	$413.9M	$393.6M	$225.8M	$280.4M	$244.7M	$197.8M	$177.6M	$128.0M	$101.3M	-$42.40M	-$11.60M	-$25.30M	-$12.50M	$129.1M	$93.20M	$143.5M	$111.0M	$21.60M	$1.700M	-$8.700M	-$3.600M	$3.700M
YoY Change	31.48%	5.16%	74.31%	-19.47%	14.59%	23.71%	11.37%	38.75%	26.36%	-338.92%	265.52%	-54.15%	102.4%	-109.68%	38.52%	-35.05%	29.28%	413.89%	1170.59%	-119.54%	141.67%	-197.3%	48.0%
Income Tax	$117.7M	$116.4M	$113.0M	$64.40M	$82.40M	$63.70M	$117.5M	$23.10M	$23.10M	$41.70M	$42.80M	$60.10M	$51.50M	$53.30M	$48.10M	$28.00M	$44.30M	$36.60M	$11.90M	$5.500M	$9.700M	$2.800M	$1.400M
% Of Pretax Income	21.63%	28.12%	28.71%	28.52%	29.39%	26.03%	59.4%	13.01%	18.05%	41.16%					37.26%	30.04%	30.87%	32.97%	55.09%	323.53%			37.84%
Net Earnings	$427.2M	$296.6M	$277.1M	$157.8M	$197.2M	$179.7M	$78.60M	$153.6M	$101.6M	$56.70M	$80.10M	$77.50M	$92.30M	$95.40M	$81.20M	$64.90M	$98.90M	$74.40M	$9.700M	-$3.900M	-$17.60M	-$6.800M	$2.700M
YoY Change	44.03%	7.04%	75.6%	-19.98%	9.74%	128.63%	-48.83%	51.18%	79.19%	-29.21%	3.35%	-16.03%	-3.25%	17.49%	25.12%	-34.38%	32.93%	667.01%	-348.72%	-77.84%	158.82%	-351.85%	22.73%
Net Earnings / Revenue	14.41%	11.72%	11.46%	7.94%	9.51%	9.48%	4.45%	9.53%	6.26%	3.13%	4.35%	4.33%	5.59%	7.31%	7.29%	5.86%	9.58%	8.74%	2.61%	-1.09%	-6.75%	-3.08%	1.54%
Basic Earnings Per Share	$2.92	$2.00	$1.83	$1.03	$1.27	$1.15	$0.50				$0.48	$0.47	$0.56	$0.58
Diluted Earnings Per Share	$2.90	$1.99	$1.812M	$1.02	$1.26	$1.14	$0.49	$947.0K	$600.8K	$334.5K	$0.48	$0.46	$0.55	$0.58	$492.4K	$391.9K	$601.9K	$464.7K	$95.94K	-$39.08K	-$216.5K	-$87.74K	$38.35K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Cash & Short-Term Investments	$488.3M	$645.5M	$1.168B	$731.8M	$684.9M	$322.4M	$439.2M	$500.3M	$468.3M	$497.5M	$438.7M	$310.6M	$246.0M	$230.4M	$207.1M	$166.2M	$332.4M	$52.10M	$62.60M	$32.50M	$25.30M	$84.80M
YoY Change	-24.35%	-44.74%	59.63%	6.85%	112.44%	-26.59%	-12.21%	6.83%	-5.87%	13.4%	41.24%	26.26%	6.77%	11.25%	24.61%	-50.0%	538.0%	-16.77%	92.62%	28.46%	-70.17%
Cash & Equivalents	$488.3M	$645.5M	$1.068B	$681.8M	$678.3M	$322.4M	$325.0M	$342.4M	$267.1M	$319.5M	$438.7M	$310.6M	$246.0M	$230.4M	$207.1M	$166.2M	$332.4M	$52.10M	$62.60M	$32.50M	$25.30M	$84.80M
Short-Term Investments		$0.00	$100.0M	$50.00M	$6.600M	$0.00	$114.2M	$157.9M	$201.2M	$178.0M
Other Short-Term Assets	$216.4M	$194.9M	$176.6M	$165.6M	$172.0M	$115.1M	$114.1M	$91.30M	$106.5M	$98.20M	$95.80M	$98.30M	$89.10M	$76.80M	$59.80M	$57.50M	$69.70M	$19.50M	$60.60M	$63.70M	$60.50M	$21.90M
YoY Change	11.03%	10.36%	6.64%	-3.72%	49.44%	0.88%	24.97%	-14.27%	8.45%	2.51%	-2.54%	10.33%	16.02%	28.43%	4.0%	-17.5%	257.44%	-67.82%	-4.87%	5.29%	176.26%
Inventory	$968.3M	$800.1M	$710.1M	$692.3M	$577.2M	$509.6M	$486.2M	$440.4M	$422.0M	$477.4M	$589.8M	$611.5M	$576.2M	$511.0M	$422.8M	$425.1M	$446.4M	$134.5M	$117.7M	$107.7M	$110.1M	$101.8M
Prepaid Expenses
Receivables	$492.0M	$472.7M	$416.9M	$335.3M	$362.2M	$357.2M	$319.3M	$243.9M	$234.7M	$293.2M	$307.6M	$289.3M	$282.8M	$232.9M	$184.1M	$171.9M	$185.2M	$79.60M	$67.90M	$67.30M	$54.70M	$48.00M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$9.000M	$6.500M	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.165B	$2.113B	$2.472B	$1.925B	$1.796B	$1.304B	$1.359B	$1.276B	$1.232B	$1.366B	$1.432B	$1.310B	$1.194B	$1.051B	$873.8M	$820.7M	$1.034B	$294.7M	$315.2M	$271.3M	$250.6M	$256.6M
YoY Change	2.45%	-14.51%	28.41%	7.16%	37.72%	-4.01%	6.5%	3.61%	-9.87%	-4.58%	9.33%	9.68%	13.6%	20.29%	6.47%	-20.61%	250.76%	-6.5%	16.18%	8.26%	-2.34%
Property, Plant & Equipment	$599.7M	$538.2M	$466.0M	$462.9M	$371.7M	$270.6M	$266.5M	$239.1M	$231.1M	$249.9M	$299.5M	$283.6M	$249.0M	$233.7M	$223.4M	$221.3M	$207.6M	$90.30M	$85.30M	$85.00M	$81.40M	$73.20M
YoY Change	11.43%	15.49%	0.67%	24.54%	37.36%	1.54%	11.46%	3.46%	-7.52%	-16.56%	5.61%	13.9%	6.55%	4.61%	0.95%	6.6%	129.9%	5.86%	0.35%	4.42%	11.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$481.2M	$231.9M	$160.9M	$111.6M	$77.30M	$59.30M	$71.00M	$93.10M	$62.10M	$37.00M	$23.90M	$30.20M	$30.80M	$30.60M	$22.70M	$21.90M	$22.40M	$2.700M	$4.000M	$3.100M	$6.400M	$9.000M
YoY Change	107.5%	44.13%	44.18%	44.37%	30.35%	-16.48%	-23.74%	49.92%	67.84%	54.81%	-20.86%	-1.95%	0.65%	34.8%	3.65%	-2.23%	729.63%	-32.5%	29.03%	-51.56%	-28.89%
Total Long-Term Assets	$2.074B	$1.499B	$1.178B	$1.124B	$975.2M	$824.3M	$589.7M	$532.5M	$498.5M	$498.5M	$556.4M	$546.7M	$516.4M	$498.7M	$298.5M	$295.6M	$277.0M	$138.5M	$108.4M	$100.2M	$100.4M	$85.60M
YoY Change	38.38%	27.19%	4.82%	15.26%	18.31%	39.78%	10.74%	6.82%	0.0%	-10.41%	1.77%	5.87%	3.55%	67.07%	0.98%	6.71%	100.0%	27.77%	8.18%	-0.2%	17.29%
Total Assets	$4.239B	$3.612B	$3.650B	$3.049B	$2.772B	$2.129B	$1.949B	$1.808B	$1.730B	$1.865B	$1.988B	$1.856B	$1.711B	$1.550B	$1.172B	$1.116B	$1.311B	$433.2M	$423.6M	$371.5M	$351.0M	$342.2M
YoY Change
Accounts Payable	$202.7M	$178.4M	$147.4M	$134.6M	$118.4M	$104.5M	$90.80M	$86.10M	$72.10M	$76.00M	$74.80M	$69.60M	$72.30M	$64.00M	$49.80M	$43.30M	$52.30M	$29.00M	$23.40M	$25.70M	$24.90M	$22.40M
YoY Change	13.62%	21.03%	9.51%	13.68%	13.3%	15.09%	5.46%	19.42%	-5.13%	1.6%	7.47%	-3.73%	12.97%	28.51%	15.01%	-17.21%	80.34%	23.93%	-8.95%	3.21%	11.16%
Accrued Expenses	$239.0M	$195.1M		$186.1M	$181.4M	$164.4M	$160.7M	$136.3M	$149.6M	$148.3M	$172.9M	$164.9M	$147.1M	$134.7M	$117.7M	$117.4M	$161.2M
YoY Change	22.5%			2.59%	10.34%	2.3%	17.9%	-8.89%	0.88%	-14.23%	4.85%	12.1%	9.21%	14.44%	0.26%	-27.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$185.5M	$100.0K	$22.70M	$13.20M	$19.40M	$7.300M	$10.20M	$16.40M	$11.80M
YoY Change													-100.0%	185400.0%	-99.56%	71.97%	-31.96%	165.75%	-28.43%	-37.8%	38.98%
Long-Term Debt Due	$121.2M	$18.70M	$112.4M	$2.200M	$500.0K	$18.50M	$0.00	$20.10M	$600.0K	$800.0K	$700.0K	$1.300M	$83.70M	$28.90M	$21.90M	$18.30M	$22.40M	$2.500M	$2.200M	$2.000M	$2.200M	$6.600M
YoY Change	548.13%	-83.36%	5009.09%	340.0%	-97.3%		-100.0%	3250.0%	-25.0%	14.29%	-46.15%	-98.45%	189.62%	31.96%	19.67%	-18.3%	796.0%	13.64%	10.0%	-9.09%	-66.67%
Total Short-Term Liabilities	$1.191B	$914.3M	$938.5M	$791.9M	$645.6M	$599.3M	$524.5M	$524.7M	$554.5M	$582.7M	$648.6M	$681.8M	$755.8M	$831.5M	$540.5M	$519.7M	$561.1M	$195.1M	$147.9M	$111.2M	$108.6M	$96.90M
YoY Change	30.26%	-2.58%	18.51%	22.66%	7.73%	14.26%	-0.04%	-5.37%	-4.84%	-10.16%	-4.87%	-9.79%	-9.1%	53.84%	4.0%	-7.38%	187.6%	31.91%	33.0%	2.39%	12.07%
Long-Term Debt	$1.160B	$1.201B	$1.222B	$842.3M	$812.8M	$322.6M	$415.6M	$391.6M	$265.2M	$354.2M	$354.3M	$335.9M	$219.4M	$86.60M	$115.7M	$182.8M	$8.600M	$22.90M	$25.10M	$27.80M	$26.40M	$17.40M
YoY Change	-3.35%	-1.74%	45.06%	3.63%	151.95%	-22.38%	6.13%	47.66%	-25.13%	-0.03%	5.48%	53.1%	153.35%	-25.15%	-36.71%	2025.58%	-62.45%	-8.76%	-9.71%	5.3%	51.72%
Other Long-Term Liabilities	$474.2M	$302.9M	$358.9M	$397.4M	$326.1M	$227.9M	$250.6M	$188.9M	$167.9M	$138.4M	$112.6M	$116.9M	$86.60M	$85.50M	$72.10M	$80.10M	$105.5M	$23.50M	$20.20M	$15.20M	$13.50M	$15.90M
YoY Change	56.55%	-15.6%	-9.69%	21.86%	43.09%	-9.06%	32.66%	12.51%	21.32%	22.91%	-3.68%	34.99%	1.29%	18.59%	-9.99%	-24.08%	348.94%	16.34%	32.89%	12.59%	-15.09%
Total Long-Term Liabilities	$1.635B	$1.503B	$1.581B	$1.240B	$1.139B	$550.5M	$666.2M	$580.5M	$433.1M	$492.6M	$466.9M	$452.8M	$306.0M	$172.1M	$187.8M	$262.9M	$114.1M	$46.40M	$45.30M	$43.00M	$39.90M	$33.30M
YoY Change	8.72%	-4.89%	27.51%	8.85%	106.88%	-17.37%	14.76%	34.03%	-12.08%	5.5%	3.11%	47.97%	77.8%	-8.36%	-28.57%	130.41%	145.91%	2.43%	5.35%	7.77%	19.82%
Total Liabilities	$2.844B	$2.498B	$2.580B	$2.088B	$1.865B	$1.232B	$1.223B	$1.122B	$1.004B	$1.099B	$1.142B	$1.150B	$1.089B	$1.025B	$755.1M	$804.4M	$675.7M	$241.7M	$194.2M	$154.3M	$148.6M	$156.8M
YoY Change	13.86%	-3.16%	23.55%	11.96%	51.36%	0.73%	9.01%	11.76%	-8.65%	-3.79%	-0.66%	5.58%	6.23%	35.76%	-6.13%	19.05%	179.56%	24.46%	25.86%	3.84%	-5.23%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Basic Shares Outstanding	146.4	148.6	151.4	153.4M	155.2M	156.2M	158.1M	161.4M	168.2M	167.8M	166.5M shares	166.0M shares	165.4M shares	164.4M shares
Diluted Shares Outstanding	147.2	149.4	152.9	154.6M	156.6M	157.2M	159.1M				168.5M shares	167.4M shares	166.9M shares	165.7M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $9.8452 Billion

About Bruker Corp

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 9,707 full-time employees. The company went IPO on 2000-08-04. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. The company also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.

Industry: Laboratory Analytical Instruments Peers: Avantor Inc Bio Rad Laboratories Inc Bio-Techne Corp Charles River Laboratories International Inc Syneos Health, Inc. Maravai LifeSciences Holdings Inc Medpace Holdings Inc REPLIGEN CORP Thermo Fisher Scientific Inc